give me a break
AGREE 100%. company with solid proven products, attractive pipeline, 3 FDA approval , good earning, bright forecast even not considering solvd, dozen of upgrade with target 132 went down 7 points in 2 days. What a manipulation.
entre bio-tech sector is having a tough day- especially the big names. Look at Jazz